Analysis of the immunoglobulin heavy chain variable region gene expression in Iranian patients with chronic lymphocytic leukemia

被引:18
作者
Farsangi, M. Hojjat
Jeddi-Tehrani, M.
Sharifian, R. A.
Razavi, S. M.
Khoshnoodi, J.
Rabbani, H.
Shokri, F. [1 ]
机构
[1] Univ Tehran Med Sci, Sch Publ Hlth, Dept Immunol, Tehran, Iran
[2] Avesina Res Inst, Monoclonal Antibody Res Ctr, Tehran, Iran
[3] Karolinska Hosp, Canc Ctr Karolinska, Immune & Gene Therapy Lab, S-10401 Stockholm, Sweden
[4] Univ Tehran Med Sci, Clin Hematol & Oncol, Vali Asr Hosp, Fac Med, Tehran, Iran
[5] Iran Univ Med Sci, Fac Med, Firozgar Hosp, Clin Hematol & Oncol, Tehran, Iran
关键词
chronic lymphocytic leukemia; leukemic B-cell; immunoglobulin; heavy chain variable region (VH); VH gene family; RT-PCR;
D O I
10.1080/10428190601043310
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
B-cell chronic lymphocytic leukemia (B-CLL) results from clonal expansion of phenotypically mature but functionally immature B-lymphocytes. The incidence of this type of leukemia is low in Asian countries, whereas it is the most frequent type of leukemia in the West. Previous investigations mainly conducted in Western populations have demonstrated nonrandom rearrangement of certain immunoglobulin variable region heavy (VH) and/or light (VL) chain genes in different groups of B-CLL patients. Little is known about the profile of VH gene expression in Asian patients. In the present study, we determined the frequency of VH gene family usage in 59 Iranian patients with B-CLL. VH gene family of patients was determined by reverse transcriptase-polymerase chain reaction using VH1-VH7 family specific primers. The most frequently expressed VH gene family was found to be VH3 (45.8%) followed by VH4 (32.2%), VH1 (18.6%), VH5 (1.7%) and VH6 (1.7%), with no expression of VH2 and VH7 gene families. The results indicate a lower representation of the VH1 and VH2 gene families and a higher representation of the VH4 gene family in Iranian B-CLL patients compared to Western patients, suggesting involvement of ethnic and/or environmental factors in B-CLL disease initiation.
引用
收藏
页码:109 / 116
页数:8
相关论文
共 49 条
[1]  
BREZINSCHEK HP, 1995, J IMMUNOL, V155, P190
[2]  
BYRD JC, 2004, HEMATOLOGY, V1, P163
[3]   National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment [J].
Cheson, BD ;
Bennett, JM ;
Grever, M ;
Kay, N ;
Keating, MJ ;
OBrien, S ;
Rai, KR .
BLOOD, 1996, 87 (12) :4990-4997
[4]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[5]   THE HUMAN-IMMUNOGLOBULIN V-H REPERTOIRE [J].
COOK, GP ;
TOMLINSON, IM .
IMMUNOLOGY TODAY, 1995, 16 (05) :237-242
[6]   ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia [J].
Crespo, M ;
Bosch, F ;
Villamor, N ;
Bellosillo, B ;
Colomer, D ;
Rozman, M ;
Marcé, S ;
López-Guillermo, A ;
Campo, E ;
Montserrat, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (18) :1764-1775
[7]  
Duke VM, 2003, HAEMATOLOGICA, V88, P1259
[8]   Restricted immunoglobulin V-H region repertoire in chronic lymphocytic leukemia patients with autoimmune hemolytic anemia [J].
Efremov, DG ;
Ivanovski, M ;
Siljanovski, N ;
Pozzato, G ;
Cevreska, L ;
Fais, F ;
Chiorazzi, N ;
Batista, FD ;
Burrone, OR .
BLOOD, 1996, 87 (09) :3869-3876
[9]   Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors [J].
Fais, F ;
Ghiotto, F ;
Hashimoto, S ;
Sellars, B ;
Valetto, A ;
Allen, SL ;
Schulman, P ;
Vinciguerra, VP ;
Rai, K ;
Rassenti, LZ ;
Kipps, TJ ;
Dighiero, G ;
Schroeder, HW ;
Ferrarini, M ;
Chiorazzi, N .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (08) :1515-1525
[10]   The VH gene repertoire of splenic B cells and somatic hypermutation in systemic lupus erythematosus [J].
Fraser, NLW ;
Rowley, G ;
Field, M ;
Stott, DI .
ARTHRITIS RESEARCH & THERAPY, 2003, 5 (02) :R114-R121